AMSBIO has introduced a new range of Deubiquitinating (DUB) enzyme assay kits, simplifying routine protein analysis in the ubiquitin-proteasome system. Designed in a 96-well microplate format, these ready-to-use kits require no substrate preparation, enabling researchers to perform fast, accurate DUB profiling with minimal setup.

These assays utilize fluorophore-conjugated ubiquitin derivatives for high-sensitivity detection at 485/535 nm, offering reproducible results across purified enzymes and cell-based models. Targeted kits for key DUBs like BAP1, USP7, and UCHL1 support disease-focused studies and compound screening.

With applications spanning cancer biology, neurodegeneration, and immunology, AMSBIO’s DUB enzyme kits are tailored for rapid kinetic or endpoint analysis, supporting both academic and industry researchers in high-throughput workflows.